============ Forwarded message ============
From : Maria Majewska
To : <undisclosed-recipients:;>
Date : Mon, 02 Jul 2012 01:37:44 +0200
Subject : Wrost zgonów,powikłań poszczepiennych
============ Forwarded message ============
Witam,
Załączony poniżej wykres pokazuje przypadki zarejestrowanych zgonów poszczepiennych w latach pd 1990 do maja 2012. Obserwuje się wyraźny trend wzrostowy wynikajacy prawdopodobnie z większej liczby stosowanych szczepionek oraz ich większej toksyczności. Najbardziej zabójcze są szczepionki najsilniej promowane lub wymuszane zarówno dla niemowląt i małych dzieci , jak i dla dorosłych.
W tabelkach pokazane są przypadki zgonów i powikłań poszczepiennych zarejestrowane w bazie VAERS (w USA) tylko w latach 2010-2011(a więc dotyczą współcześnie stosowanych szczepionek). Wcześniejsze analizy FDA wskazywały, że rejestruje się tylko od 1 do 10 % wszystkich prawdopodobnych przypadków powikłań po lekach czy szczepieniach, nowsze pokazały, że rejestruje się ich średnio ok. 6%, co znaczy, że liczby zgłoszonych przypadków należy pomnożyć przez ok. 17.
Najwiecej zgonów zarejestrowano po szczepionkach zawierających kompotenty DTAP-Hib-IPV, przeciw grypowych, przeciw pneumokokom, przeciw Hep B.
Ciężkie powikłania poszczepinne najczęściej wystepowały po szczepieniach zawierajacych komponenty DTaP-Hib-IPV, przeciw grypowych, przeciw pneumokokom, przeciw HPV, Hep B, oraz MMR
W kontekscie tysiecy zgonów i setek tysiecy lub milionów powikłań poszczepiennych zmuszanie (przez Sanepid) rodziców do szczepienia swych dzieci ociera się o zbrodnię ludobójstwa. W żadnym cywilizowanym kraju żadna instytucja nie ma prawa zmuszać ludzi do przyjmowania jakichkolwiek szczepień czy innych zabiegów medycznych. Również Polska Konstytucja zabrania takich praktyk. Wszędzie szczepienia są tylko dobrowolne. Polska jest tu niechlubnym, wręcz haniebym wyjątkiem. Nie ulega wątpliwości, że wynika to z faktu, że Polska, bedąc stosunkowo małym krajem, jest dziś największym w świecie poligonem testowania leków i szczepionek. W Polsce nawet nie rejestruje się zgonów i powikłań poszczepiennych czy polekowych. Zabite szczepionkami dzieci i dorosłe osoby bezceremonialnie wymazuje się ze zbiorowej pamięci. Skoro dziś dla zysków szczepionkami zabija się zdrowe dzieci, należy oczekiwać, że wkrótce bedzie się je rozbierać także na organy.
Zgony poszczepienne zarejestrowane w VAERS w latach 1990-(maj 2012). 5040 zarejestrowanych zgonów, czyli wszystkich mogło być ok. 86 000.
|
HPV |
Zgony zarejestrowane w latach 2010/2011 po różnych typach szczepionek (pomnożyć przez 17).
|
||||
|
ANTHRAX VACCINE (ANTH) |
1 |
0.15% |
||
|
BACILLUS CALMETTE-GUERIN VACCINE (BCG) |
15 |
2.27% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS ACELLULAR PERTUSSIS POLIOVIRUS INACTIVATED HAEMOPHILUS INFLUENZA B AND HEPATITIS B VACCINE (HEXAVAX) (6VAX-F) |
19 |
2.88% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (DTAP) |
25 |
3.79% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE (DTP) |
17 |
2.58% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS PERTUSSIS AND HAEMOPHILUS INFLUENZA B VACCINE (HEXAVAX) (DTPHIB) |
1 |
0.15% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS, PEDIATRIC (DT) |
1 |
0.15% |
||
|
Diphtheria/tetanus/pertussis/hepatitis B (DTPHEP) |
2 |
0.30% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + HEPATITIS B + INACTIVATED POLIOVIRUS VACCINE (DTAPHEPBIP) |
17 |
2.58% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE(DTAPIPV) |
4 |
0.61% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (DTAPIPVHIB) |
93 |
14.09% |
||
|
DTP-IPV COMBINED DTP AND IPV VACCINE (DTPIPV) |
1 |
0.15% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) (DTPPHIB) |
2 |
0.30% |
||
|
HAEMOPHILUS B CONJUGATE VACCINE (HIBV) |
64 |
9.70% |
||
|
HEPATITIS A (HEPA) |
18 |
2.73% |
||
|
HEPATITIS A AND HEPATITIS B VACCINE (HEPAB) |
7 |
1.06% |
||
|
HEPATITIS B VACCINE (HEP) |
72 |
10.91% |
||
|
HUMAN PAPILLOVAVIRUS BIVALENT (HPV2) |
3 |
0.45% |
||
|
HUMAN PAPILLOMAVIRUS (TYPES 6, 11, 16, 18) RECOMBINANT VACCINE (HPV4) |
43 |
6.52% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT (FLU(H1N1)) |
74 |
11.21% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT, INTRANASAL SPRAY (FLUN(H1N1)) |
3 |
0.45% |
||
|
INFLUENZA (SEASONAL) VIRUS VACCINE (FLU(SEASONAL)) |
160 |
24.24% |
||
|
INFLUENZA (SEASONAL) INTRANASAL VACCINE (FLUMIST) (FLUN(SEASONAL)) |
6 |
0.91% |
||
|
JAPANESE ENCEPHALITIS VIRUS VACCINE (JEV) |
1 |
0.15% |
||
|
MEASLES AND RUBELLA VACCINE (MER) |
1 |
0.15% |
||
|
MEASLES VACCINE (MEA) |
1 |
0.15% |
||
|
MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE (MMR) |
30 |
4.55% |
||
|
MENINGOCOCCAL POLYSACCHARIDE VACCINE (MEN) |
9 |
1.36% |
||
|
MENINGOCOCCAL VACCINE (MENACTRA) (MNQ) |
16 |
2.42% |
||
|
PERTUSSIS, ADSORBED VACCINE (PER) |
1 |
0.15% |
||
|
PNEUMOCOCCAL VACCINE, POLYVALENT (PPV) |
41 |
6.21% |
||
|
PNEUMOCOCCAL, 7-VALENT VACCINE (PREVNAR) (PNC) |
98 |
14.85% |
||
|
PNEUMOCOCCAL, 13-VALENT VACCINE (PREVNAR) (PNC13) |
89 |
13.48% |
||
|
POLIOVIRUS VACCINE INACTIVATED (IPV) |
27 |
4.09% |
||
|
POLIOVIRUS VACCINE TRIVALENT, LIVE, ORAL (OPV) |
11 |
1.67% |
||
|
RABIES VIRUS VACCINE (RAB) |
7 |
1.06% |
||
|
Rotavirus Vaccine (ROTHB5) |
60 |
9.09% |
||
|
ROTAVIRUS VACCINE LIVE (ROT) |
5 |
0.76% |
||
|
ROTAVIRUS VACCINE (ROTH1) |
29 |
4.39% |
||
|
SMALLPOX VACCINE (SMALL) |
1 |
0.15% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (BOOSTRIX/ADACEL) (TDAP) |
13 |
1.97% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS, ADULT (TD) |
3 |
0.45% |
||
|
TETANUS TOXOID (TTOX) |
1 |
0.15% |
||
|
TETRAMUNE (DTAPH) |
1 |
0.15% |
||
|
TYPHOID VACCINE (TYP) |
2 |
0.30% |
||
|
VARIVAX-VARICELLA VIRUS LIVE (VARCEL) |
21 |
3.18% |
||
|
YELLOW FEVER VACCINE (YF) |
4 |
0.61% |
||
|
ZOSTER VACCINE LIVE (VARZOS) |
11 |
1.67% |
||
|
UNKNOWN VACCINES (UNK) |
2 |
0.30% |
||
|
Total |
1,133 |
171.67% |
Zarejestrowane powikłania w latach 2010-2011 po różnych typach szczepionek (pomnożyć przez 17).
|
||||
|
ANTHRAX VACCINE (ANTH) |
709 |
1.04% |
||
|
BACILLUS CALMETTE-GUERIN VACCINE (BCG) |
41 |
0.06% |
||
|
CHOLERA VACCINE (CHOL) |
11 |
0.02% |
||
|
COMVAX (HBHEPB) |
38 |
0.06% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS ACELLULAR PERTUSSIS POLIOVIRUS INACTIVATED HAEMOPHILUS INFLUENZA B AND HEPATITIS B VACCINE (HEXAVAX) (6VAX-F) |
628 |
0.92% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (DTAP) |
3,852 |
5.64% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE (DTP) |
496 |
0.73% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS PERTUSSIS AND HAEMOPHILUS INFLUENZA B VACCINE (HEXAVAX)(DTPHIB) |
21 |
0.03% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS, PEDIATRIC (DT) |
119 |
0.17% |
||
|
DIPHTHERIA TOXOID (DTOX) |
16 |
0.02% |
||
|
Diphtheria/Pertussis/Polio (oral [live] or inactivated not noted) (DPP) |
33 |
0.05% |
||
|
Diphtheria/tetanus/pertussis/hepatitis B (DTPHEP) |
14 |
0.02% |
||
|
Diphtheria/Tetanus/whole pertussis-Inactivated Polio Virus-Haemophilus influenza b (Pentacoqr) (DTPIHI) |
10 |
0.01% |
||
|
DT-IPV COMBINED DT AND IPV VACCINE (DTIPV) |
42 |
0.06% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + HEPATITIS B + INACTIVATED POLIOVIRUS VACCINE (DTAPHEPBIP) |
788 |
1.15% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE (DTAPIPV) |
1,578 |
2.31% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (DTAPIPVHIB) |
2,544 |
3.73% |
||
|
DTP-IPV COMBINED DTP AND IPV VACCINE (DTPIPV) |
48 |
0.07% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) (DTPPHIB) |
23 |
0.03% |
||
|
PANDEMIC FLU VACCINE (H5N1) |
1 |
0.00% |
||
|
HAEMOPHILUS B CONJUGATE VACCINE (HIBV) |
2,878 |
4.22% |
||
|
HAEMOPHILUS B POLYSACCHARIDE VACCINE (HBPV) |
8 |
0.01% |
||
|
HEPATITIS A (HEPA) |
4,374 |
6.41% |
||
|
HEPATITIS A AND HEPATITIS B VACCINE (HEPAB) |
754 |
1.10% |
||
|
HEPATITIS A AND TYPHOID VACCINES (HEPATYP) |
5 |
0.01% |
||
|
HEPATITIS B VACCINE (HEP) |
3,291 |
4.82% |
||
|
HUMAN PAPILLOVAVIRUS BIVALENT (HPV2) |
1,672 |
2.45% |
||
|
HUMAN PAPILLOMAVIRUS (TYPES 6, 11, 16, 18) RECOMBINANT VACCINE (HPV4) |
5,932 |
8.69% |
||
|
HUMAN PAPILLOMAVIRUS VACCINE (HPV) |
118 |
0.17% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT (FLU(H1N1)) |
5,466 |
8.01% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT, INTRANASAL SPRAY (FLUN(H1N1)) |
1,108 |
1.62% |
||
|
INFLUENZA (SEASONAL) VIRUS VACCINE (FLU(SEASONAL)) |
18,532 |
27.15% |
||
|
INFLUENZA (SEASONAL) INTRANASAL VACCINE (FLUMIST) (FLUN(SEASONAL)) |
1,635 |
2.40% |
||
|
JAPANESE ENCEPHALITIS VIRUS VACCINE (JEV) |
46 |
0.07% |
||
|
JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED, ADSORBED (JEV1) |
41 |
0.06% |
||
|
LYME VACCINE (LYMERIX) (LYME) |
3 |
0.00% |
||
|
MEASLES AND MUMPS VIRUS VACCINE, LIVE (MM) |
7 |
0.01% |
||
|
MEASLES AND RUBELLA VACCINE (MER) |
4 |
0.01% |
||
|
MEASLES VACCINE (MEA) |
59 |
0.09% |
||
|
MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE (MMR) |
6,083 |
8.91% |
||
|
MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (PROQUAD) (MMRV) |
562 |
0.82% |
||
|
MENINGOCOCCAL CONJUGATE VACCINE (MNC) |
8 |
0.01% |
||
|
MENINGOCOCCAL POLYSACCHARIDE VACCINE (MEN) |
483 |
0.71% |
||
|
MENINGOCOCCAL VACCINE (MENACTRA) (MNQ) |
3,116 |
4.57% |
||
|
MUMPS AND RUBELLA VIRUS VACCINE, LIVE (MUR) |
4 |
0.01% |
||
|
MUMPS VIRUS VACCINE, LIVE (MU) |
18 |
0.03% |
||
|
PERTUSSIS, ADSORBED VACCINE (PER) |
43 |
0.06% |
||
|
PNEUMOCOCCAL VACCINE, POLYVALENT (PPV) |
5,893 |
8.63% |
||
|
PNEUMOCOCCAL, 7-VALENT VACCINE (PREVNAR) (PNC) |
2,883 |
4.22% |
||
|
PNEUMOCOCCAL, 13-VALENT VACCINE (PREVNAR) (PNC13) |
3,912 |
5.73% |
||
|
POLIOVIRUS VACCINE INACTIVATED (IPV) |
2,384 |
3.49% |
||
|
POLIOVIRUS VACCINE TRIVALENT, LIVE, ORAL (OPV) |
130 |
0.19% |
||
|
RABIES VIRUS VACCINE (RAB) |
354 |
0.52% |
||
|
Rotavirus Vaccine (ROTHB5) |
2,217 |
3.25% |
||
|
ROTAVIRUS VACCINE (ROTASHIELD) (RV) |
2 |
0.00% |
||
|
ROTAVIRUS VACCINE LIVE (ROT) |
174 |
0.25% |
||
|
ROTAVIRUS VACCINE (ROTH1) |
856 |
1.25% |
||
|
RUBELLA VACCINE (RUB) |
34 |
0.05% |
||
|
SMALLPOX VACCINE (SMALL) |
522 |
0.76% |
||
|
SUMMER/SPRING ENCEPHALITIS VACCINE (SSE) (SSEV) |
4 |
0.01% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (BOOSTRIX/ADACEL) (TDAP) |
6,672 |
9.78% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS, ADULT (TD) |
524 |
0.77% |
||
|
TETANUS TOXOID (TTOX) |
211 |
0.31% |
||
|
TETRAMUNE (DTAPH) |
32 |
0.05% |
||
|
TICK-BORNE ENCEPHALITIS VACCINE (TBE) (TBE) |
11 |
0.02% |
||
|
TYPHOID VACCINE (TYP) |
804 |
1.18% |
||
|
VARIVAX-VARICELLA VIRUS LIVE (VARCEL) |
7,547 |
11.06% |
||
|
YELLOW FEVER VACCINE (YF) |
405 |
0.59% |
||
|
ZOSTER VACCINE LIVE (VARZOS) |
3,008 |
4.41% |
||
|
UNKNOWN VACCINES (UNK) |
443 |
0.65% |
||
|
Total |
106,284 |
155.72% |
Zarejestrowane ciężkie powikłania (w tym trwale okaleczenia) w latach 2010/2011 po różnych typach szczepionek (pomnożyć przez 17).
|
||||
|
ANTHRAX VACCINE (ANTH) |
93 |
0.93% |
||
|
BACILLUS CALMETTE-GUERIN VACCINE (BCG) |
29 |
0.29% |
||
|
CHOLERA VACCINE (CHOL) |
4 |
0.04% |
||
|
COMVAX (HBHEPB) |
17 |
0.17% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS ACELLULAR PERTUSSIS POLIOVIRUS INACTIVATED HAEMOPHILUS INFLUENZA B AND HEPATITIS B VACCINE (HEXAVAX) (6VAX-F) |
427 |
4.26% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (DTAP) |
531 |
5.29% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE (DTP) |
255 |
2.54% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS PERTUSSIS AND HAEMOPHILUS INFLUENZA B VACCINE (HEXAVAX) (DTPHIB) |
11 |
0.11% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS, PEDIATRIC (DT) |
16 |
0.16% |
||
|
DIPHTHERIA TOXOID (DTOX) |
1 |
0.01% |
||
|
Diphtheria/Pertussis/Polio (oral [live] or inactivated not noted) (DPP) |
6 |
0.06% |
||
|
Diphtheria/tetanus/pertussis/hepatitis B (DTPHEP) |
8 |
0.08% |
||
|
Diphtheria/Tetanus/whole pertussis-Inactivated Polio Virus-Haemophilus influenza b (Pentacoqr) (DTPIHI) |
2 |
0.02% |
||
|
DT-IPV COMBINED DT AND IPV VACCINE (DTIPV) |
17 |
0.17% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + HEPATITIS B + INACTIVATED POLIOVIRUS VACCINE (DTAPHEPBIP) |
160 |
1.60% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE(DTAPIPV) |
119 |
1.19% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (DTAPIPVHIB) |
711 |
7.09% |
||
|
DTP-IPV COMBINED DTP AND IPV VACCINE (DTPIPV) |
26 |
0.26% |
||
|
DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE + INACTIVATED POLIOVIRUS VACCINE + HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) (DTPPHIB) |
12 |
0.12% |
||
|
HAEMOPHILUS B CONJUGATE VACCINE (HIBV) |
807 |
8.05% |
||
|
HAEMOPHILUS B POLYSACCHARIDE VACCINE (HBPV) |
2 |
0.02% |
||
|
HEPATITIS A (HEPA) |
376 |
3.75% |
||
|
HEPATITIS A AND HEPATITIS B VACCINE (HEPAB) |
165 |
1.65% |
||
|
HEPATITIS A AND TYPHOID VACCINES (HEPATYP) |
1 |
0.01% |
||
|
HEPATITIS B VACCINE (HEP) |
709 |
7.07% |
||
|
HUMAN PAPILLOVAVIRUS BIVALENT (HPV2) |
330 |
3.29% |
||
|
HUMAN PAPILLOMAVIRUS (TYPES 6, 11, 16, 18) RECOMBINANT VACCINE (HPV4) |
813 |
8.11% |
||
|
HUMAN PAPILLOMAVIRUS VACCINE (HPV) |
20 |
0.20% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT (FLU(H1N1)) |
942 |
9.39% |
||
|
INFLUENZA A (H1N1) 2009 MONOVALENT, INTRANASAL SPRAY (FLUN(H1N1)) |
48 |
0.48% |
||
|
INFLUENZA (SEASONAL) VIRUS VACCINE (FLU(SEASONAL)) |
2,213 |
22.06% |
||
|
INFLUENZA (SEASONAL) INTRANASAL VACCINE (FLUMIST) (FLUN(SEASONAL)) |
99 |
0.99% |
||
|
JAPANESE ENCEPHALITIS VIRUS VACCINE (JEV) |
10 |
0.10% |
||
|
JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED, ADSORBED (JEV1) |
7 |
0.07% |
||
|
MEASLES AND MUMPS VIRUS VACCINE, LIVE (MM) |
2 |
0.02% |
||
|
MEASLES AND RUBELLA VACCINE (MER) |
2 |
0.02% |
||
|
MEASLES VACCINE (MEA) |
9 |
0.09% |
||
|
MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE (MMR) |
590 |
5.88% |
||
|
MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (PROQUAD) (MMRV) |
28 |
0.28% |
||
|
MENINGOCOCCAL CONJUGATE VACCINE (MNC) |
4 |
0.04% |
||
|
MENINGOCOCCAL POLYSACCHARIDE VACCINE (MEN) |
140 |
1.40% |
||
|
MENINGOCOCCAL VACCINE (MENACTRA) (MNQ) |
182 |
1.81% |
||
|
MUMPS AND RUBELLA VIRUS VACCINE, LIVE (MUR) |
1 |
0.01% |
||
|
MUMPS VIRUS VACCINE, LIVE (MU) |
2 |
0.02% |
||
|
PERTUSSIS, ADSORBED VACCINE (PER) |
2 |
0.02% |
||
|
PNEUMOCOCCAL VACCINE, POLYVALENT (PPV) |
748 |
7.46% |
||
|
PNEUMOCOCCAL, 7-VALENT VACCINE (PREVNAR) (PNC) |
1,081 |
10.78% |
||
|
PNEUMOCOCCAL, 13-VALENT VACCINE (PREVNAR) (PNC13) |
849 |
8.46% |
||
|
POLIOVIRUS VACCINE INACTIVATED (IPV) |
422 |
4.21% |
||
|
POLIOVIRUS VACCINE TRIVALENT, LIVE, ORAL (OPV) |
64 |
0.64% |
||
|
RABIES VIRUS VACCINE (RAB) |
95 |
0.95% |
||
|
Rotavirus Vaccine (ROTHB5) |
765 |
7.63% |
||
|
ROTAVIRUS VACCINE (ROTASHIELD) (RV) |
2 |
0.02% |
||
|
ROTAVIRUS VACCINE LIVE (ROT) |
29 |
0.29% |
||
|
ROTAVIRUS VACCINE (ROTH1) |
446 |
4.45% |
||
|
RUBELLA VACCINE (RUB) |
8 |
0.08% |
||
|
SMALLPOX VACCINE (SMALL) |
99 |
0.99% |
||
|
SUMMER/SPRING ENCEPHALITIS VACCINE (SSE) (SSEV) |
1 |
0.01% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (BOOSTRIX/ADACEL) (TDAP) |
422 |
4.21% |
||
|
TETANUS AND DIPHTHERIA TOXOIDS, ADULT (TD) |
59 |
0.59% |
||
|
TETANUS TOXOID (TTOX) |
13 |
0.13% |
||
|
TETRAMUNE (DTAPH) |
6 |
0.06% |
||
|
TICK-BORNE ENCEPHALITIS VACCINE (TBE) (TBE) |
8 |
0.08% |
||
|
TYPHOID VACCINE (TYP) |
107 |
1.07% |
||
|
VARIVAX-VARICELLA VIRUS LIVE (VARCEL) |
395 |
3.94% |
||
|
YELLOW FEVER VACCINE (YF) |
68 |
0.68% |
||
|
ZOSTER VACCINE LIVE (VARZOS) |
173 |
1.72% |
||
|
UNKNOWN VACCINES (UNK) |
65 |
0.65% |
||
|
Total |
15,874 |
158.27% |
